局部万古霉素粉末能否作为选择?一项随机对照试验,比较局部应用万古霉素粉末与标准术后抗生素在全膝关节置换术中预防术后感染的安全性。
试验1年时提前终止,因为治疗组假体周围感染比例显著更高(3例,3.75%)而对照组为0例(P=0.03)。结论认为局部万古霉素粉末在降低全膝关节置换术后假体周围感染发生率方面劣于标准术后静脉抗生素。
要点
- 治疗组术中局部应用1克万古霉素粉末且不使用术后抗生素,对照组使用标准术后静脉抗生素。
- 治疗组3例(3.75%)诊断假体周围感染,对照组0例,差异显著(P=0.03)。
- 试验因治疗组假体周围感染比例显著更高而在1年时提前终止。
核心结论
- 本试验表明,在降低全膝关节置换术后假体周围感染发生率方面,局部应用万古霉素粉末劣于标准术后静脉抗生素。
研究设计与样本
- 双盲、非劣效随机对照试验,80例随机分配至治疗组,85例分配至对照组。
- 所有参与者均在皮肤切开前60分钟内接受标准术前静脉抗生素(头孢唑林/万古霉素)。
主要发现
- 治疗组平均年龄66岁,对照组64岁;治疗组BMI 35.7,对照组33.4;治疗组糖尿病患者16例,对照组13例。
- 治疗组3例(3.75%)诊断为假体周围感染,对照组0例,差异显著(P=0.03)。
关键数值与推荐
- 治疗组术中由骨科医生局部应用1克万古霉素粉末(500毫克直接置于假体上,500毫克置于闭合的关节囊上方),且不接受术后抗生素。
- 对照组接受标准术后静脉抗生素。
- 主要结局为手术后42天内急性手术部位感染的发生率。
临床怎么用
- 原文未据此给出推荐。
局限性
- 试验因治疗组假体周围感染比例显著更高(P=0.03)而在1年时提前终止。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The demand for total knee arthroplasties (TKAs) is expected to rise in the coming decades, increasing the burden of periprosthetic joint infections (PJIs). The use of intrawound vancomycin powder (VP) has proven to be effective in reducing the incidence of PJIs after spinal surgery. That said, its effectiveness in TKA remains unclear. This trial aims to examine the efficacy of intrawound vancomycin powder first versus standard postoperative antibiotics in preventing PJIs after TKA. METHODS: This study was a double-blinded, noninferiority, randomized controlled trial. All participants received standard preoperative intravenous (IV) antibiotics (Cefazolin/Vancomycin) within 60 minutes of skin incision. Patients in the treatment group received 1 gram of VP applied intraoperatively by the orthopedic surgeon (500 mg directly on the prosthesis, 500 mg above the closed joint capsule). These patients did not receive postoperative antibiotics. Patients in the control group received standard postoperative IV antibiotics. The primary outcome was the incidence of acute surgical site infection within 42 days of procedure. RESULTS: There were 80 patients randomized to the treatment group and 85 patients randomized to the control. Groups were matched with respect to baseline characteristics, including average age (66 versus 64), BMI (35.7 versus 33.4), and diabetics (16 versus 13). The trial was halted at 1 year as a significantly greater proportion (P = .03) of patients in the treatment group (n = 3, 3.75%) were diagnosed with PJIs compared to the control (n = 0). CONCLUSION: Our trial demonstrated the intrawound application of VP to be inferior to standard postoperative IV antibiotics in reducing the incidence of PJIs after TKA.
引用
- Abuzaiter W, Bolton CA, Drakos A, et al. Is Topical Vancomycin an Option? A Randomized Controlled Trial to Determine the Safety of the Topical Use of Vancomycin Powder in Preventing Postoperative Infections in Total Knee Arthroplasty, as Compared With Standard Postoperative Antibiotics. J Arthroplasty. 2023. PMID: 36736635. doi:10.1016/j.arth.2023.01.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。